Happy 90th Birthday to Dr. George Martin
July 05, 2017 in Research
On June 30, 2017, Professor Emeritus Dr. George Martin turned 90 years old. Several generations of Dr. Martin's colleagues in the UW Department of Pathology gathered to hear remarks, mingle, and celebrate Martin's work and legacy of scientific accomplishment, generosity, and collegiality.
Read the full story on the UW Memory and Brain Wellness Center website.
Stealing a Secret From an Unwelcome Virus
June 29, 2017 in Research
Dr. Jia Zhu's unexpected discovery in a herpes lab might bring relief to cancer patients.
Dr. Bharadwaj And Mentor Dr. Pallanck Receive Weil Award
June 29, 2017 in Research
Dr. Raj Bharadwaj and his mentor Dr. Leo Pallanck received the Weil Award this year for Best Paper on Experimental Neuropathology from the American Association of Neuropathologists for their work on a new Drosophila model of Neurodegeneration with Brain Iron Accumulation (NBIA). This is a major national award not limited to trainees awarded for Raj's work in the research year of his neuropathology fellowship. The new Drosophila model of NBIA – a familial disease with clinical and pathologic similarities to Parkinson’s disease- is anticipated to help better understand the pathogenesis of Parkinsonism, with the ultimate goal of finding novel therapeutic approaches for these devastating diseases.
Donated Brains a ‘Tremendous Gift’ to Science, UW Medicine Says
May 18, 2017 in Research
King 5 has published an article on brain donations and the benefits they provide to medical institutions. Dr. Keene was interviewed on the importance of brain donations in general and their potential to improve treatment and prevention of traumatic brain injuries.
More can be found on King 5's website, "Donated Brains a 'Tremendous Gift' to Science, UW Medicine Says".
Martin Lab’s Aging Research Featured as Biology Focus in Nautilus
March 30, 2017 in Research
Nautilus Magazine has published an article on aging featuring George Martin's and others' research on aging and the wide variability in its effects. The article can be found on the Nautilus website and contains more information on the genetic focus of Martin's research.
Kaeberlein Lab’s Research in Dog Aging Project Featured in TIME
March 21, 2017 in Research
TIME has published an article featuring the Kaeberlein Lab's work on the Dog Aging Project, a trial which is studying the effects of rapamycin therapy in dogs. The drug is being tested for the potential of increasing the length and quality of life in aging canines.
You can read the article on TIME's website, "Is There Anything That Can Help My Dog Live Longer Too?".
Young and Keene featured in the Winter 2017 issue of Dimensions, the Newsletter of the UW ADRC
January 30, 2017 in Research
Dr. Young and Dr. Keene were featured in the Winter 2017 issue of Dimensions, the Newsletter of the UW Alzheimer's Disease Research Center. You can read about their work, which focuses on human induced pluripotent stem cells (iPSCs) for the development of laboratory models of Alzheimer’s disease, on the UW Memory and Brain Wellness Center website.
Stevens Receives NIH Director’s New Innovator Award
October 06, 2016 in Research
Kelly Stevens, Assistant Professor of Bioengineering and Pathology, has received an NIH Director's New Innovator Award in support of her work to develop new technologies to assemble artifical human tissues from stem cells, and then remotely control these tissues after implantation in a patient.
Yeung Receives Multiple Honors
September 21, 2016 in Research
Cecilia Yeung, Assistant Professor of Pathology, has recently won the SEED grant from the Hope Foundation, the SWOG Young Investigator Award, and the Archer Research Challenge Grant.
Kaeberlein Study on Rapamycin Therapy Published in eLife
August 26, 2016 in Research
The scientific journal eLife has published the latest results of a study led by Matt Kaeberlein, Professor of Pathology, and Piper Treuting, Associate Professor of Comparative Medicine and Chief of Comparative Pathology, on the long-term effects of short-term therapy on middle-aged mice treated with the drug rapamycin.